Results 161 to 170 of about 507,437 (241)

SurvDB: Systematic Identification of Potential Prognostic Biomarkers in 33 Cancer Types. [PDF]

Int J Mol Sci
Wu Z, Min C, Cao W, Xue F, Wu X, Yang Y, Yang J, Niu X, Gong J.   +8 more
europepmc   +1 more source

Regional and patient characteristic disparities in the outcomes of minimally invasive surgery for colorectal cancer in Japan

Annals of Gastroenterological Surgery, EarlyView.
This study aimed to clarify whether differences in minimally invasive surgery outcomes are associated with regional and patient characteristics. This study found regional and patient characteristic disparities in minimally invasive surgical outcomes; national policies should be implemented to address these inequities.
Atsushi Hamabe, Arata Takahashi, Hiraku Kumamaru, Hiroshi Hasegawa, Koki Otsuka, Yoshihiro Kakeji, Ken Shirabe, Masafumi Inomata, Yuko Kitagawa, Ichiro Takemasa   +9 more
wiley   +1 more source

Prognostic Factors for Visual Postsurgical Outcome in Rhegmatogenous Retinal Detachment-A Systematic Review. [PDF]

J Clin Med
Chereji G, Samoilă O, Nicoară SD.
europepmc   +1 more source

Role of radiotherapy in surgical approaches to pancreatic cancer treatment: A narrative review

Annals of Gastroenterological Surgery, EarlyView.
This review explores the role of radiotherapy (RT) in the multidisciplinary treatment of pancreatic ductal adenocarcinoma (PDAC), focusing on its integration with surgical strategies to improve resectability, local control, and survival outcomes while addressing potential challenges and future research directions.
Satoshi Yasuda, Minako Nagai, Kota Nakamura, Yasuko Matsuo, Masayuki Sho   +4 more
wiley   +1 more source

Prognostic value of elevated cardiac troponin in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. [PDF]

Front Neurol
Zhao J, Gu S, Zhao X, Wang S, Pan Q, Zou C.   +5 more
europepmc   +1 more source

A Novel Mixed Convolution Transformer Model for the Fast and Accurate Diagnosis of Glioma Subtypes

Advanced Intelligent Systems, EarlyView.
The mixed convolutional transformer model represents a novel approach for the accurate and rapid diagnosis of glioma subtypes. This model employs advanced, complex layers and functions, establishing its uniqueness and enhancing its ability to deliver precise outcomes in glioma subtype detection.
S. M. Nuruzzaman Nobel, S. M. Masfequier Rahman Swapno, Md Babul Islam, AKM Azad, Salem A. Alyami, Md Alamin, Pietro Liò, Mohammad Ali Moni   +7 more
wiley   +1 more source

Construction of a poor prognosis prediction and visualization system for intracranial aneurysm endovascular intervention treatment based on an improved machine learning model. [PDF]

Front Neurol
Lei C, Fu A, Li B, Zhou S, Liu J, Cao Y, Zhou B.   +6 more
europepmc   +1 more source

TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management

American Journal of Hematology, EarlyView.
ABSTRACT Alterations in the tumor suppressor gene TP53 are common in human cancers and are associated with an aggressive nature. Approximately 8%–12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) harbor TP53 mutations (TP53mut) and present immense challenges due to inherent chemoresistance and poor outcomes.
Mithun Vinod Shah, Daniel A. Arber, Devendra K. Hiwase   +2 more
wiley   +1 more source

Ethics and end-of-life in pediatric and neonatal ICUs: a systematic review of recommendations. [PDF]

BMC Palliat Care
Špoljar D, Janković S, Vrkić D, McNamara G, Ćurković M, Novak M, Filipović-Grčić B, Grosek S, Gastmans C, Gordijn B, Borovečki A.   +10 more
europepmc   +1 more source

Belantamab Mafodotin Plus Proteasome Inhibition Efficacy Versus Comparators in Early Relapsed Myeloma: A Systematic Review and Network Meta‐Analysis

American Journal of Hematology, EarlyView.
ABSTRACT In the Phase 3 DREAMM‐7 study of patients with relapsed/refractory multiple myeloma (RRMM) who received ≥ 1 prior therapy, belantamab mafodotin plus bortezomib and dexamethasone (BVd) demonstrated a progression‐free survival (PFS) benefit versus daratumumab plus bortezomib and dexamethasone (DVd).
Joshua Richter, Ajay Nooka, Paula Rodríguez‐Otero, Fredrik Schjesvold, Eirini Katodritou, Emily Combe, Marianne Scott, Leanne Cooper, Indeg Sly, Nick Ballew, Jacopo Bitetti, Natalie Boytsov, Molly Purser, Simon McNamara   +13 more
wiley   +1 more source